High Solubility and no Tendency to Aggregate

Gibbs WW.  Nanobodies.  Sci Am. 2005 Aug; 293 (2): 78-83.

Conrath K, Vincke C, Stijlemans B, Schymkowitz J, Decanniere K, Wyns L, Muyldermans S, Loris R.  Antigen binding and solubility effects upon the veneering of a camel VHH in framework-2 to mimic a VH.  J Mol Biol. 2005 Jul 1; 350 (1): 112-25.

Nguyen VK, Desmyter A, Muyldermans S.  Functional heavy-chain antibodies in CamelidaeAdv Immunol. 2001; 79: 261-96.

Muyldermans S.  Single domain camel antibodies: current status.  J Biotechnol. 2001 Jun; 74 (4): 277-302.

Muyldermans S, Cambillau C, Wyns L.  Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains.  Trends Biochem Sci. 2001 Apr;26(4):230-5.

Davies J, Riechmann L.  Single antibody domains as small recognition units: design and in vitro antigen selection of camelised, human VH domains with improved protein stability.  Protein Eng. 1996 Jun; 9(6): 531-7.

Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Bajyana Songa E, Bendahman N, Hamers R.  Naturally occurring antibodies devoid of light chains.  Nature 1993 June 3; 363 (6428): 446-8.

 < back